Global Travel Vaccines Market Overview

Global Travel Vaccines Market was valued at USD 10.09 Billion in 2021 and is expected to reach USD 18.27 Billion by the year 2028, at a CAGR of 8.85%.

Travel vaccines which are also termed as travel immunizers/immunizations are the vaccines that people take as a precaution before visiting to any region so that they can protect themselves from a serious disease. The bodyguards itself with the help of vaccines by creating anti-bodies that will protect against several diseases. Travel vaccines are made up of bio-based formulations that are built to beat specific disease by boosting an individual’s immunity system. Travel vaccines contain agents that can be compared to the organism, which is made from a killed or weakened form of the microbe. The potency of vaccine formations is mostly accomplished by the balance of vaccine stain, the schedule of the vaccine, pathophysiology of the disease, and genetic predisposition.

According to the analyst, the increasing cases of travel-related diseases are likely to increase the size of travel vaccines market in the forecast period. Travelling is usually associated with chances particularly in regards to irresistible infections. Hence, the increasing occurrence of movement related infections will develop more interests in the Travel Vaccines Market for the production of more powerful antibodies. Recently, due to the novel corona virus that spread all across the globe in December 2019, raised the travel vaccine market exponentially. The investments done in the research and development for the procurement of the vaccine against corona virus has hiked Travel vaccines market in the year 2019-2020 and is expected to increase more during the forecast period.  

Market Dynamics And Factors For Travel Vaccines Market

Drivers:

Increasing Travel & Tourism Drives Travel Vaccines Market

As tourism & travelling have become an integral part of the human lifestyle, the travel and tourism industry has highly flourished. The tourism industry has not only added a change in the ongoing routine of people, but have also several provided opportunities to explore different cultures, spiritualism, traditions, and for medical tourism. This has been a long term growth factor for the travel vaccine market owing to its ongoing necessity. According to a survey conducted by The Millennial Travel Study by Skyscanner, over 1,000 millennials (aged 18-35) were questioned on factors, such as their preferred destination, major interests, mode of travel, and so on., and the survey displayed that a major share of population preferred traveling to international destinations over the domestic ones. The survey further stated that European destinations are a dream destination among travellers of all age groups along with the developed nations like US and New Zealand.

Also, statistics from Our World in Data which gathers and analyses data from the World Tourism Organization, stated that the increased tourism in various regions in 2019, such as the European Union witnessed nearly 966.44 million arrivals, North America with approximately 200 million arrivals, and the Middle East & North Africa showcased 128 arrivals. Furthermore, arrivals in France stood at 212 million in the year 2018, whereas European countries such as Spain saw 126.17 million arrivals in 2019. Additionally, The United Nations World Tourism Organization (UNWTO) indicated a growing number of arrivals, with 2.403 billion arrivals in 2019 and a projected expenditure of US$ 1.439 billion in international tourism. These rising number of travellers, and growth in travel & tourism industry, leads to the rapid growth in travel vaccines market all across the world.

Restraints:

Certain Temperature Requirements

Due to some market limitations, it can be very difficult to stock needful travel vaccines at an ambiguous temperature. Certain room conditions are necessary for such travel vaccinations, and unavailability of the required temperature may lead to the spoilage, thereby hampering the market growth. Also, there are various medical histories associated with the negative effects of the vaccination, which is likely to restrain the growth of travel vaccine market in the upcoming years.

COVID-19 Impact Analysis On Travel Vaccines Market

Many industries round-faced a decrease in Travel vaccines market with the emergence of the corona virus, however healthcare is one of the most hiked industry throughout the pandemic. The marketplace for travel vaccines has been on bloom due to the unfold of the sickness and people taking plenty of precautions. Further, there has been a high demand from the scientists and researchers for the vaccine against the corona virus that is increasing the scale of the market exponentially. Also, the rules and recommendation regarding travel vaccines principally self-addressed infectious diseases before the COVID-19 pandemic of 2020. However, they further revealed a discrepancy among travelers, with some selecting to not get vaccinated due to the high cost, lack of appropriate knowledge, and private preference. The economic slump has affected the worldwide manufacturers and their production capacities, whereas the pandemic-induced collapse of the airline sector has affected the logistics and supply chain as well as availability of the vaccines.

Regional Analysis Of Travel Vaccines Market

North America is the dominating region for the travel vaccine market. The growth can be attributed to the constant updates on traveling safety, crises, concerns associated with vaccine stocks, as well as the epidemic brawls in the region. Consequently, the travel vaccines market is further anticipated to witness substantial growth opportunities, with travelers and regulatory bodies stressing on vaccination to avoid various infectious diseases. Organizations such as the US Centers for Disease Control and Prevention, the National Health Services of various countries, as well as the World Health Organization formulated various travel-related advisories with an intend to ensure safe travel, leading to the rise in the travel vaccine market.

Asia-Pacific is estimated to grow at the highest growth rate in the projected period owing to the growing health awareness among the people as well as the increasing demand of advanced vaccines. The travel and tourism industry have majorly witnessed robust growth in the recent decades along with the rising disposable income of individuals, better traveling routes, a variety of transportation methods, and more. Tourism and travel industry in this region have also increased with travelers seeking to explore human behavior and cultures by exploration of different cultures, spiritualism, traditions, rural and ethnic living, thereby boosting the market growth.

Players Covered in Travel Vaccines Market are:

• Pfizer

• Sanofi

• GlaxoSmithKline

• Merck

• AstraZeneca

• Janssen Pharmaceuticals

• Abbott

• Mitsubishi Tanabe Pharma

• LG Life Sciences /  LG Chem Ltd.

• Roche

• Lupin

• Takeda Pharmaceutical

• Valeant Pharmaceuticals

• SK Chemicals

• Hualan Biological Engineering

• Novartis AG

• Dynavax Technologies

• Emergent BioSolutions Inc.

• Bharat Biotech

• Valneva SE

• GlycoVaxyn

• Indian Immunologicals

• Beijing Minhai Biotechnology

• Altimmune Inc.

• CSL Ltd.

• KM Biologics Co. Ltd.

• Mitsubishi Chemical Holdings Corp.

• Serum Institute of India Pvt. Ltd.

• Shenzhen Kangtai Biological Products Co. Ltd.

• Sinovac Biotech Ltd.

• ALK-Abelló A/S

• Bavarian Nordic A/S

• Crucell (Subsidiary of Johnson & Johnson) and other major players.

Key Industry Development In The Travel Vaccine Market

In December 2021, Emergent BioSolutions Inc. declared the first participant dosed in its phase 1 study, EBS-UFV-001, studying the safety, tolerability, and immunogenicity of its investigational universal influenza vaccine candidate. The current and updated version of this influenza vaccine candidate includes multiple components intended to induce broad and supra-seasonal immunity against influenza A viruses.

In June 2021, Merck & Co., Inc. and Sanofi successfully developed the Vaxelis vaccine (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Haemophilus b Conjugate, Inactivated Poliovirus, and Hepatitis B Vaccine) as part of a US-based partnership between both the companies. The vaccine is considered as the first hexavalent combination vaccine available in the US indicated for active immunization to help prevent DTP, polio, and hepatitis B.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Type
 3.2 By Application

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  3.5.1 Drivers
  3.5.2 Restraints
  3.5.3 Opportunities
  3.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 4: Travel Vaccines Market by Type
 4.1 Travel Vaccines Market Overview Snapshot and Growth Engine
 4.2 Travel Vaccines Market Overview
 4.3 Mono Vaccines
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size (2016-2028F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Mono Vaccines: Grographic Segmentation
 4.4 Combination Vaccines
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size (2016-2028F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Combination Vaccines: Grographic Segmentation
 4.5 Others
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size (2016-2028F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Others: Grographic Segmentation

Chapter 5: Travel Vaccines Market by Application
 5.1 Travel Vaccines Market Overview Snapshot and Growth Engine
 5.2 Travel Vaccines Market Overview
 5.3 Domestic Travel
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Domestic Travel: Grographic Segmentation
 5.4 Outbound Travel
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Outbound Travel: Grographic Segmentation
 5.5 Other
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Other: Grographic Segmentation

Chapter 6: Company Profiles and Competitive Analysis
 6.1 Competitive Landscape
  6.1.1 Competitive Positioning
  6.1.2 Travel Vaccines Sales and Market Share By Players
  6.1.3 Industry BCG Matrix
  6.1.4 Ansoff Matrix
  6.1.5 Travel Vaccines Industry Concentration Ratio (CR5 and HHI)
  6.1.6 Top 5 Travel Vaccines Players Market Share
  6.1.7 Mergers and Acquisitions
  6.1.8 Business Strategies By Top Players
 6.2 PFIZER
  6.2.1 Company Overview
  6.2.2 Key Executives
  6.2.3 Company Snapshot
  6.2.4 Operating Business Segments
  6.2.5 Product Portfolio
  6.2.6 Business Performance
  6.2.7 Key Strategic Moves and Recent Developments
  6.2.8 SWOT Analysis
 6.3 SANOFI
 6.4 GLAXOSMITHKLINE
 6.5 MERCK
 6.6 ASTRAZENECA
 6.7 JANSSEN PHARMACEUTICALS
 6.8 ABBOTT
 6.9 MITSUBISHI TANABE PHARMA
 6.10 LG LIFE SCIENCES
 6.11 ROCHE
 6.12 LUPIN
 6.13 TAKEDA PHARMACEUTICAL
 6.14 VALEANT PHARMACEUTICALS
 6.15 SK CHEMICALS
 6.16 HUALAN BIOLOGICAL ENGINEERING

Chapter 7: Global Travel Vaccines Market Analysis, Insights and Forecast, 2016-2028
 7.1 Market Overview
 7.2 Historic and Forecasted Market Size By Type
  7.2.1 Mono Vaccines
  7.2.2 Combination Vaccines
  7.2.3 Others
 7.3 Historic and Forecasted Market Size By Application
  7.3.1 Domestic Travel
  7.3.2 Outbound Travel
  7.3.3 Other

Chapter 8: North America Travel Vaccines Market Analysis, Insights and Forecast, 2016-2028
 8.1 Key Market Trends, Growth Factors and Opportunities
 8.2 Impact of Covid-19
 8.3 Key Players
 8.4 Key Market Trends, Growth Factors and Opportunities
 8.4 Historic and Forecasted Market Size By Type
  8.4.1 Mono Vaccines
  8.4.2 Combination Vaccines
  8.4.3 Others
 8.5 Historic and Forecasted Market Size By Application
  8.5.1 Domestic Travel
  8.5.2 Outbound Travel
  8.5.3 Other
 8.6 Historic and Forecast Market Size by Country
  8.6.1 U.S.
  8.6.2 Canada
  8.6.3 Mexico

Chapter 9: Europe Travel Vaccines Market Analysis, Insights and Forecast, 2016-2028
 9.1 Key Market Trends, Growth Factors and Opportunities
 9.2 Impact of Covid-19
 9.3 Key Players
 9.4 Key Market Trends, Growth Factors and Opportunities
 9.4 Historic and Forecasted Market Size By Type
  9.4.1 Mono Vaccines
  9.4.2 Combination Vaccines
  9.4.3 Others
 9.5 Historic and Forecasted Market Size By Application
  9.5.1 Domestic Travel
  9.5.2 Outbound Travel
  9.5.3 Other
 9.6 Historic and Forecast Market Size by Country
  9.6.1 Germany
  9.6.2 U.K.
  9.6.3 France
  9.6.4 Italy
  9.6.5 Russia
  9.6.6 Spain

Chapter 10: Asia-Pacific Travel Vaccines Market Analysis, Insights and Forecast, 2016-2028
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Type
  10.4.1 Mono Vaccines
  10.4.2 Combination Vaccines
  10.4.3 Others
 10.5 Historic and Forecasted Market Size By Application
  10.5.1 Domestic Travel
  10.5.2 Outbound Travel
  10.5.3 Other
 10.6 Historic and Forecast Market Size by Country
  10.6.1 China
  10.6.2 India
  10.6.3 Japan
  10.6.4 Southeast Asia

Chapter 11: South America Travel Vaccines Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Type
  11.4.1 Mono Vaccines
  11.4.2 Combination Vaccines
  11.4.3 Others
 11.5 Historic and Forecasted Market Size By Application
  11.5.1 Domestic Travel
  11.5.2 Outbound Travel
  11.5.3 Other
 11.6 Historic and Forecast Market Size by Country
  11.6.1 Brazil
  11.6.2 Argentina

Chapter 12: Middle East & Africa Travel Vaccines Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Type
  12.4.1 Mono Vaccines
  12.4.2 Combination Vaccines
  12.4.3 Others
 12.5 Historic and Forecasted Market Size By Application
  12.5.1 Domestic Travel
  12.5.2 Outbound Travel
  12.5.3 Other
 12.6 Historic and Forecast Market Size by Country
  12.6.1 Saudi Arabia
  12.6.2 South Africa

Chapter 13 Investment Analysis

Chapter 14 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. TRAVEL VACCINES MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. TRAVEL VACCINES MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. TRAVEL VACCINES MARKET COMPETITIVE RIVALRY
TABLE 005. TRAVEL VACCINES MARKET THREAT OF NEW ENTRANTS
TABLE 006. TRAVEL VACCINES MARKET THREAT OF SUBSTITUTES
TABLE 007. TRAVEL VACCINES MARKET BY TYPE
TABLE 008. MONO VACCINES MARKET OVERVIEW (2016-2028)
TABLE 009. COMBINATION VACCINES MARKET OVERVIEW (2016-2028)
TABLE 010. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 011. TRAVEL VACCINES MARKET BY APPLICATION
TABLE 012. DOMESTIC TRAVEL MARKET OVERVIEW (2016-2028)
TABLE 013. OUTBOUND TRAVEL MARKET OVERVIEW (2016-2028)
TABLE 014. OTHER MARKET OVERVIEW (2016-2028)
TABLE 015. NORTH AMERICA TRAVEL VACCINES MARKET, BY TYPE (2016-2028)
TABLE 016. NORTH AMERICA TRAVEL VACCINES MARKET, BY APPLICATION (2016-2028)
TABLE 017. N TRAVEL VACCINES MARKET, BY COUNTRY (2016-2028)
TABLE 018. EUROPE TRAVEL VACCINES MARKET, BY TYPE (2016-2028)
TABLE 019. EUROPE TRAVEL VACCINES MARKET, BY APPLICATION (2016-2028)
TABLE 020. TRAVEL VACCINES MARKET, BY COUNTRY (2016-2028)
TABLE 021. ASIA PACIFIC TRAVEL VACCINES MARKET, BY TYPE (2016-2028)
TABLE 022. ASIA PACIFIC TRAVEL VACCINES MARKET, BY APPLICATION (2016-2028)
TABLE 023. TRAVEL VACCINES MARKET, BY COUNTRY (2016-2028)
TABLE 024. MIDDLE EAST & AFRICA TRAVEL VACCINES MARKET, BY TYPE (2016-2028)
TABLE 025. MIDDLE EAST & AFRICA TRAVEL VACCINES MARKET, BY APPLICATION (2016-2028)
TABLE 026. TRAVEL VACCINES MARKET, BY COUNTRY (2016-2028)
TABLE 027. SOUTH AMERICA TRAVEL VACCINES MARKET, BY TYPE (2016-2028)
TABLE 028. SOUTH AMERICA TRAVEL VACCINES MARKET, BY APPLICATION (2016-2028)
TABLE 029. TRAVEL VACCINES MARKET, BY COUNTRY (2016-2028)
TABLE 030. PFIZER: SNAPSHOT
TABLE 031. PFIZER: BUSINESS PERFORMANCE
TABLE 032. PFIZER: PRODUCT PORTFOLIO
TABLE 033. PFIZER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 033. SANOFI: SNAPSHOT
TABLE 034. SANOFI: BUSINESS PERFORMANCE
TABLE 035. SANOFI: PRODUCT PORTFOLIO
TABLE 036. SANOFI: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 036. GLAXOSMITHKLINE: SNAPSHOT
TABLE 037. GLAXOSMITHKLINE: BUSINESS PERFORMANCE
TABLE 038. GLAXOSMITHKLINE: PRODUCT PORTFOLIO
TABLE 039. GLAXOSMITHKLINE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 039. MERCK: SNAPSHOT
TABLE 040. MERCK: BUSINESS PERFORMANCE
TABLE 041. MERCK: PRODUCT PORTFOLIO
TABLE 042. MERCK: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 042. ASTRAZENECA: SNAPSHOT
TABLE 043. ASTRAZENECA: BUSINESS PERFORMANCE
TABLE 044. ASTRAZENECA: PRODUCT PORTFOLIO
TABLE 045. ASTRAZENECA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 045. JANSSEN PHARMACEUTICALS: SNAPSHOT
TABLE 046. JANSSEN PHARMACEUTICALS: BUSINESS PERFORMANCE
TABLE 047. JANSSEN PHARMACEUTICALS: PRODUCT PORTFOLIO
TABLE 048. JANSSEN PHARMACEUTICALS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 048. ABBOTT: SNAPSHOT
TABLE 049. ABBOTT: BUSINESS PERFORMANCE
TABLE 050. ABBOTT: PRODUCT PORTFOLIO
TABLE 051. ABBOTT: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 051. MITSUBISHI TANABE PHARMA: SNAPSHOT
TABLE 052. MITSUBISHI TANABE PHARMA: BUSINESS PERFORMANCE
TABLE 053. MITSUBISHI TANABE PHARMA: PRODUCT PORTFOLIO
TABLE 054. MITSUBISHI TANABE PHARMA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 054. LG LIFE SCIENCES: SNAPSHOT
TABLE 055. LG LIFE SCIENCES: BUSINESS PERFORMANCE
TABLE 056. LG LIFE SCIENCES: PRODUCT PORTFOLIO
TABLE 057. LG LIFE SCIENCES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 057. ROCHE: SNAPSHOT
TABLE 058. ROCHE: BUSINESS PERFORMANCE
TABLE 059. ROCHE: PRODUCT PORTFOLIO
TABLE 060. ROCHE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 060. LUPIN: SNAPSHOT
TABLE 061. LUPIN: BUSINESS PERFORMANCE
TABLE 062. LUPIN: PRODUCT PORTFOLIO
TABLE 063. LUPIN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 063. TAKEDA PHARMACEUTICAL: SNAPSHOT
TABLE 064. TAKEDA PHARMACEUTICAL: BUSINESS PERFORMANCE
TABLE 065. TAKEDA PHARMACEUTICAL: PRODUCT PORTFOLIO
TABLE 066. TAKEDA PHARMACEUTICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 066. VALEANT PHARMACEUTICALS: SNAPSHOT
TABLE 067. VALEANT PHARMACEUTICALS: BUSINESS PERFORMANCE
TABLE 068. VALEANT PHARMACEUTICALS: PRODUCT PORTFOLIO
TABLE 069. VALEANT PHARMACEUTICALS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 069. SK CHEMICALS: SNAPSHOT
TABLE 070. SK CHEMICALS: BUSINESS PERFORMANCE
TABLE 071. SK CHEMICALS: PRODUCT PORTFOLIO
TABLE 072. SK CHEMICALS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 072. HUALAN BIOLOGICAL ENGINEERING: SNAPSHOT
TABLE 073. HUALAN BIOLOGICAL ENGINEERING: BUSINESS PERFORMANCE
TABLE 074. HUALAN BIOLOGICAL ENGINEERING: PRODUCT PORTFOLIO
TABLE 075. HUALAN BIOLOGICAL ENGINEERING: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. TRAVEL VACCINES MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. TRAVEL VACCINES MARKET OVERVIEW BY TYPE
FIGURE 012. MONO VACCINES MARKET OVERVIEW (2016-2028)
FIGURE 013. COMBINATION VACCINES MARKET OVERVIEW (2016-2028)
FIGURE 014. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 015. TRAVEL VACCINES MARKET OVERVIEW BY APPLICATION
FIGURE 016. DOMESTIC TRAVEL MARKET OVERVIEW (2016-2028)
FIGURE 017. OUTBOUND TRAVEL MARKET OVERVIEW (2016-2028)
FIGURE 018. OTHER MARKET OVERVIEW (2016-2028)
FIGURE 019. NORTH AMERICA TRAVEL VACCINES MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 020. EUROPE TRAVEL VACCINES MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 021. ASIA PACIFIC TRAVEL VACCINES MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 022. MIDDLE EAST & AFRICA TRAVEL VACCINES MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 023. SOUTH AMERICA TRAVEL VACCINES MARKET OVERVIEW BY COUNTRY (2016-2028)